National BioService got the awards of the “Exporter of the Year”


The RVC Biofund portfolio company of "National BioService" (NBS) became the winner of the district stage of the All-Russian "Exporter of the Year" award in the North-West Federal District.


The award is annually awarded to organizations and individual entrepreneurs who have achieved the greatest success in the export implementation of non-resource non-energy goods, works, services, as well as the intellectual activity results. In 2019, more than thousands of participants were invited to take part in the contest. According to the expert evaluation results National BioService company won the first place in nomination of “Exporter of the Year in the Services”

Among the nominee assessment criteria are the development dynamics of new markets and foreign client number, export nomenclature expansion, international awards and prizes, participation in international exhibitions and conferences.

NBS is the first research biobank and bioservice in Russia. The business model created by the NBS is unique not only for Russia — the company combines its own laboratories resources in its work, ensuring high quality and standards of works performed, and attracting a partner network of medical organizations in many Russian regions, which makes it possible to carry out large-scale projects. Including the projects within the National Technology Initiative and the Skolkovo Technology Park. Among the main export markets for the NBS services are the United Kingdom, Germany, Switzerland, Sweden, Norway, Denmark, the USA, and Japan.


National BioService (NBS)

NBS is the first research biobank and bioservice in Russia operating in strict compliance with high international standards and principles of ethics, transparency and mutually beneficial cooperation with customers and partners. National BioService performs the key element role of the biomedical research infrastructure in Russia, deeply integrated into international activities to improve the human health and develop the personalized medicine. NBS provides a wide range of professional services in the area of search, laboratory processing, analysis and storage of biological samples, as well as development of research products and materials based on cellular and tissue technologies. NBS is the RVC Biofund portfolio company, as well as is one of the Helsnet market companies of the National Technology Initiative.

About affiliated funds of RVC

RVC’s affiliated funds include the RVC Seed Investment Fund, DIC Civil Technologies Fund, RVC Biofund, and RVC InfraFund. The RVC affiliated fund portfolio includes about 100 companies in high-tech economy industries, including ExoAtlet, Ubic Technologies, National BioService, CGRM Genetico, IBRiS, etc. The management company is RVC InfraFund. The total amount of asset under management is RUB 5.9 billion.

Search by name:

Search by date:

Select date in calendar
Select date in calendar